BACKGROUND AND PURPOSE: After admission to the hospital of patients with aneurysmal subarachnoid hemorrhage, we assessed the predictive value of the extent of the hemorrhage on computed tomography in addition to that of clinical grading scales for poor outcome, infarction, and rebleeding. METHODS: We studied 471 consecutive patients with aneurysmal subarachnoid hemorrhage and used logistic regression with step-wise forward selection of variables. RESULTS: On admission, poor outcome was predicted by a low Glasgow Coma Scale score (odds ratio, 0.8; 95% confidence interval, 0.7-0.9); treatment with fluid restriction (2.5; 1.6-4.0); age over 52 (2.6; 1.7-3.9); loss of consciousness at ictus (1.7; 1.1-2.6); or a large amount of subarachnoid blood (2.0; 1.3-3.1). Delayed infarction was predicted by a large amount of subarachnoid blood (1.8; 1.2-2.6) or treatment with tranexamic acid (1.6; 1.1-2.4). Rebleeding was predicted by treatment with tranexamic acid (0.4; 0.3-0.7; protective effect); age over 52 (1.9; 1.2-3.0); loss of consciousness at ictus (1.7; 1.1-2.7); or admission to a neurosurgery service (0.6; 0.3-0.9; protective effect). Comparison of the observed and predicted outcome events showed that inclusion of the amount of subarachnoid blood into a predictive model added little to the prediction of poor outcome in general, but much to the prediction of delayed cerebral ischemia. CONCLUSIONS: The total amount of subarachnoid blood on the initial computed tomogram has independent predictive power for the occurrence of delayed cerebral ischemia.
BACKGROUND AND PURPOSE: After admission to the hospital of patients with aneurysmal subarachnoid hemorrhage, we assessed the predictive value of the extent of the hemorrhage on computed tomography in addition to that of clinical grading scales for poor outcome, infarction, and rebleeding. METHODS: We studied 471 consecutive patients with aneurysmal subarachnoid hemorrhage and used logistic regression with step-wise forward selection of variables. RESULTS: On admission, poor outcome was predicted by a low Glasgow Coma Scale score (odds ratio, 0.8; 95% confidence interval, 0.7-0.9); treatment with fluid restriction (2.5; 1.6-4.0); age over 52 (2.6; 1.7-3.9); loss of consciousness at ictus (1.7; 1.1-2.6); or a large amount of subarachnoid blood (2.0; 1.3-3.1). Delayed infarction was predicted by a large amount of subarachnoid blood (1.8; 1.2-2.6) or treatment with tranexamic acid (1.6; 1.1-2.4). Rebleeding was predicted by treatment with tranexamic acid (0.4; 0.3-0.7; protective effect); age over 52 (1.9; 1.2-3.0); loss of consciousness at ictus (1.7; 1.1-2.7); or admission to a neurosurgery service (0.6; 0.3-0.9; protective effect). Comparison of the observed and predicted outcome events showed that inclusion of the amount of subarachnoid blood into a predictive model added little to the prediction of poor outcome in general, but much to the prediction of delayed cerebral ischemia. CONCLUSIONS: The total amount of subarachnoid blood on the initial computed tomogram has independent predictive power for the occurrence of delayed cerebral ischemia.
Authors: Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong Journal: J Cereb Blood Flow Metab Date: 2010-11-03 Impact factor: 6.200
Authors: J Michael Schmidt; Sang-Bae Ko; Raimund Helbok; Pedro Kurtz; R Morgan Stuart; Mary Presciutti; Luis Fernandez; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Jan Claassen; Stephan A Mayer Journal: Stroke Date: 2011-03-24 Impact factor: 7.914
Authors: A M Naidech; J Drescher; P Tamul; A Shaibani; H H Batjer; M J Alberts Journal: J Neurol Neurosurg Psychiatry Date: 2006-07-04 Impact factor: 10.154
Authors: Nicholas A Morris; David Robinson; J Michael Schmidt; Hans Peter Frey; Soojin Park; Sachin Agarwal; E Sander Connolly; Jan Claassen Journal: Resuscitation Date: 2017-12-15 Impact factor: 5.262
Authors: Khalid A Hanafy; R Morgan Stuart; Luis Fernandez; J Michael Schmidt; Jan Claassen; Kiwon Lee; E Sander Connolly; Stephan A Mayer; Neeraj Badjatia Journal: J Clin Neurosci Date: 2009-12-08 Impact factor: 1.961
Authors: Stefan A Dupont; Eelco F M Wijdicks; Edward M Manno; Giuseppe Lanzino; Robert D Brown; Alejandro A Rabinstein Journal: Neurocrit Care Date: 2009-05-16 Impact factor: 3.210